ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease

[1]  S. Shi,et al.  miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2 , 2016, Oncotarget.

[2]  K. Brown,et al.  A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis. , 2016, Cell reports.

[3]  J. Basu,et al.  Exogenous Nef is an inhibitor of Mycobacterium tuberculosis -induced tumor necrosis factor-α production and macrophage apoptosis , 2016, The Journal of Biological Chemistry.

[4]  H. Freeze,et al.  The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation , 2015, Science Signaling.

[5]  B. Fiebich,et al.  microRNA‐26a modulates inflammatory response induced by toll‐like receptor 4 stimulation in microglia , 2015, Journal of neurochemistry.

[6]  C. Banchio,et al.  Coordinated induction of GST and MRP2 by cAMP in Caco-2 cells: Role of protein kinase A signaling pathway and toxicological relevance. , 2015, Toxicology and applied pharmacology.

[7]  V. Natarajan,et al.  All-Trans Retinoic Acid Induces TGF-β2 in Intestinal Epithelial Cells via RhoA- and p38α MAPK-Mediated Activation of the Transcription Factor ATF2 , 2015, PloS one.

[8]  H. Okamura,et al.  Stimulus-selective induction of the orphan nuclear receptor NGFIB underlies different influences of angiotensin II and potassium on the human adrenal gland zona glomerulosa-specific 3β-HSD isoform gene expression in adrenocortical H295R cells. , 2015, Endocrine journal.

[9]  Chunbao Guo,et al.  Bim and VDAC1 are hierarchically essential for mitochondrial ATF2 mediated cell death , 2015, Cancer Cell International.

[10]  Semi Kim,et al.  Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition. , 2015, Carcinogenesis.

[11]  T. Ideker,et al.  Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy , 2015, Oncogene.

[12]  Ying-Jung Chen,et al.  Simvastatin induces NFκB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells. , 2014, Biochemical pharmacology.

[13]  S. Lowe,et al.  In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer , 2014, Nature Medicine.

[14]  Yuka Maruyama,et al.  AP-1-Mediated Expression of Brain-Specific Class IVa β-Tubulin in P19 Embryonal Carcinoma Cells , 2014, The Journal of veterinary medical science.

[15]  Yi Tie,et al.  MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration. , 2014, Oncology reports.

[16]  I. Ellis,et al.  Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer , 2014, Breast Cancer Research and Treatment.

[17]  S. Alonso,et al.  The Unfolded Protein Response and the Phosphorylations of Activating Transcription Factor 2 in the trans-Activation of il23a Promoter Produced by β-Glucans* , 2014, The Journal of Biological Chemistry.

[18]  Z. Meng,et al.  GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells , 2014, PloS one.

[19]  Ya-Chun Yang,et al.  MCAF1 and Rta-Activated BZLF1 Transcription in Epstein-Barr Virus , 2014, PloS one.

[20]  T. Nielsen,et al.  Activating transcription factor 2 in mesenchymal tumors. , 2014, Human pathology.

[21]  Daniel R. Zerbino,et al.  Ensembl 2014 , 2013, Nucleic Acids Res..

[22]  T. Jiang,et al.  miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells , 2014, Journal of Neuro-Oncology.

[23]  H. Hsieh,et al.  Upregulation of COX-2/PGE2 by ET-1 Mediated Through Ca2+-Dependent Signals in Mouse Brain Microvascular Endothelial Cells , 2014, Molecular Neurobiology.

[24]  J. Bourdon,et al.  Uncovering the role of p53 splice variants in human malignancy: a clinical perspective , 2013, OncoTargets and therapy.

[25]  E. Schwarz,et al.  TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages , 2013, Journal of Cell Science.

[26]  M. Mahajan,et al.  Regulation of Gγ-Globin Gene by ATF2 and Its Associated Proteins through the cAMP-Response Element , 2013, PloS one.

[27]  M. Krause,et al.  Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis. , 2013, Cancer research.

[28]  F. Zhang,et al.  The expression of p-ATF2 involved in the chondeocytes apoptosis of an endemic osteoarthritis, Kashin-Beck disease , 2013, BMC Musculoskeletal Disorders.

[29]  R. Schneider-Stock,et al.  ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells , 2013, Journal of cellular and molecular medicine.

[30]  D. Ye,et al.  Mechanism of IL-1β Modulation of Intestinal Epithelial Barrier Involves p38 Kinase and Activating Transcription Factor-2 Activation , 2013, The Journal of Immunology.

[31]  Z. Ronai,et al.  Inhibition of Melanoma Growth by Small Molecules That Promote the Mitochondrial Localization of ATF2 , 2013, Clinical Cancer Research.

[32]  M. Manns,et al.  A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration , 2013, Cell.

[33]  Changchuan Xie,et al.  Phosphorylation of ATF2 and interaction with NFY induces c-Jun in the gonadotrope , 2013, Molecular and Cellular Endocrinology.

[34]  M. Alló,et al.  Alternative splicing: a pivotal step between eukaryotic transcription and translation , 2013, Nature Reviews Molecular Cell Biology.

[35]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[36]  R. Fisher,et al.  The Expression of Embryonic Liver Development Genes in Hepatitis C Induced Cirrhosis and Hepatocellular Carcinoma , 2012, Cancers.

[37]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[38]  Eric Lau,et al.  ATF2 – at the crossroad of nuclear and cytosolic functions , 2012, Journal of Cell Science.

[39]  Kevin B. Jones,et al.  Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. , 2012, Cancer cell.

[40]  T. Ideker,et al.  PKCε Promotes Oncogenic Functions of ATF2 in the Nucleus while Blocking Its Apoptotic Function at Mitochondria , 2012, Cell.

[41]  Chang-Deng Hu,et al.  Critical Role of N-terminal End-localized Nuclear Export Signal in Regulation of Activating Transcription Factor 2 (ATF2) Subcellular Localization and Transcriptional Activity* , 2012, The Journal of Biological Chemistry.

[42]  V. Todorov,et al.  Identification of ATF2 as a transcriptional regulator of renin gene , 2012, Biological chemistry.

[43]  H. Hsieh,et al.  NADPH oxidase-mediated redox signal contributes to lipoteichoic acid-induced MMP-9 upregulation in brain astrocytes , 2012, Journal of Neuroinflammation.

[44]  Y. Minami,et al.  Dissection of Wnt5a-Ror2 Signaling Leading to Matrix Metalloproteinase (MMP-13) Expression* , 2011, The Journal of Biological Chemistry.

[45]  S. Razzouk,et al.  Activating transcription factor‐2 in survival mechanisms in head and neck carcinoma cells , 2011, Head & neck.

[46]  P. Wolters,et al.  Interleukin-1β Induces Increased Transcriptional Activation of the Transforming Growth Factor-β-activating Integrin Subunit β8 through Altering Chromatin Architecture* , 2011, The Journal of Biological Chemistry.

[47]  W. Park,et al.  Coordinated Regulation of ATF2 by miR-26b in γ-Irradiated Lung Cancer Cells , 2011, PloS one.

[48]  E. Dudenhausen,et al.  Auto-activation of c-JUN Gene by Amino Acid Deprivation of Hepatocellular Carcinoma Cells Reveals a Novel c-JUN-mediated Signaling Pathway* , 2011, The Journal of Biological Chemistry.

[49]  S. Ko,et al.  Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients. , 2011, American journal of cancer research.

[50]  M. Vigneron,et al.  A Cytoplasmic Negative Regulator Isoform of ATF7 Impairs ATF7 and ATF2 Phosphorylation and Transcriptional Activity , 2011, PloS one.

[51]  D. Theodorescu,et al.  RREB1 transcription factor splice variants in urologic cancer. , 2011, The American journal of pathology.

[52]  Jiwon Ahn,et al.  The activation of p38 MAPK primarily contributes to UV-induced RhoB expression by recruiting the c-Jun and p300 to the distal CCAAT box of the RhoB promoter. , 2011, Biochemical and biophysical research communications.

[53]  Young-Choon Lee,et al.  Transcriptional activation of human GM3 synthase (hST3Gal V) gene by valproic acid in ARPE-19 human retinal pigment epithelial cells. , 2011, BMB reports.

[54]  N. Jones,et al.  Loss of ATF2 Function Leads to Cranial Motoneuron Degeneration during Embryonic Mouse Development , 2011, PloS one.

[55]  F. Villarroya,et al.  Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue* , 2011, The Journal of Biological Chemistry.

[56]  K. Yasuda,et al.  ATF2 Interacts with β-Cell-enriched Transcription Factors, MafA, Pdx1, and Beta2, and Activates Insulin Gene Transcription* , 2011, The Journal of Biological Chemistry.

[57]  W. Dai,et al.  Hyperosmotic Stress-induced ATF-2 Activation through Polo-like Kinase 3 in Human Corneal Epithelial Cells* , 2010, The Journal of Biological Chemistry.

[58]  M. Levy,et al.  Calcineurin/Nuclear Factor of Activated T Cells and MAPK Signaling Induce TNF-α Gene Expression in Pancreatic Islet Endocrine Cells* , 2010, The Journal of Biological Chemistry.

[59]  A. Salameh,et al.  Growth Factor Stimulation Induces Cell Survival by c-Jun·ATF2-dependent Activation of Bcl-XL* , 2010, The Journal of Biological Chemistry.

[60]  J. Bahn,et al.  Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways , 2010, Oncogene.

[61]  Rajendran Sanalkumar,et al.  ATF2 maintains a subset of neural progenitors through CBF1/Notch independent Hes‐1 expression and synergistically activates the expression of Hes‐1 in Notch‐dependent neural progenitors , 2010, Journal of neurochemistry.

[62]  V. Kashyap,et al.  Thrombin induces endothelial arginase through AP-1 activation. , 2010, American journal of physiology. Cell physiology.

[63]  M. Hyman,et al.  cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) Expression* , 2010, The Journal of Biological Chemistry.

[64]  W. Rainey,et al.  Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. , 2010, Endocrinology.

[65]  Li Liu,et al.  cJun modulates Ggamma-globin gene expression via an upstream cAMP response element. , 2010, Blood cells, molecules & diseases.

[66]  J. Basu,et al.  Exogenous Nef Is an Inhibitor of Mycobacterium tuberculosis-induced Tumor Necrosis Factor-α Production and Macrophage Apoptosis* , 2010, The Journal of Biological Chemistry.

[67]  Z. Ronai,et al.  Emerging roles of ATF2 and the dynamic AP1 network in cancer , 2010, Nature Reviews Cancer.

[68]  B. Holzmann,et al.  The Neuropeptide Calcitonin Gene-related Peptide Causes Repression of Tumor Necrosis Factor-α Transcription and Suppression of ATF-2 Promoter Recruitment in Toll-like Receptor-stimulated Dendritic Cells♦ , 2009, The Journal of Biological Chemistry.

[69]  S. Ishii,et al.  The Role of ATF-2 Family Transcription Factors in Adipocyte Differentiation: Antiobesity Effects of p38 Inhibitors , 2009, Molecular and Cellular Biology.

[70]  B. Dérijard,et al.  Identification of a Novel Amino Acid Response Pathway Triggering ATF2 Phosphorylation in Mammals , 2009, Molecular and Cellular Biology.

[71]  S. Ishii,et al.  ATF-2 regulates lipopolysaccharide-induced transcription in macrophage cells. , 2009, Biochemical and biophysical research communications.

[72]  Modesto Orozco,et al.  Alternative Splicing of Transcription Factors' Genes: Beyond the Increase of Proteome Diversity , 2009, Comparative and functional genomics.

[73]  Qingshan Li,et al.  AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19* , 2009, The Journal of Biological Chemistry.

[74]  K. Urabe,et al.  Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget’s disease , 2009, Journal of cutaneous pathology.

[75]  N. Yamaguchi,et al.  Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription* , 2009, Journal of Biological Chemistry.

[76]  M. Kristiansen,et al.  The proapoptotic dp5 gene is a direct target of the MLK-JNK-c-Jun pathway in sympathetic neurons , 2009, Nucleic acids research.

[77]  Chang Gun Kim,et al.  Transcription of the protein kinase C-δ gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin , 2008, Experimental & Molecular Medicine.

[78]  E. Nishida,et al.  Expression of the transcriptional repressor ATF3 in gonadotrophs is regulated by Egr-1, CREB, and ATF2 after gonadotropin-releasing hormone receptor stimulation. , 2008, Endocrinology.

[79]  Han Liu,et al.  Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. , 2008, Cancer research.

[80]  T. Petro,et al.  Promoter Analysis Reveals Critical Roles for SMAD-3 and ATF-2 in Expression of IL-23 p19 in Macrophages1 , 2008, The Journal of Immunology.

[81]  K. Urabe,et al.  Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma. , 2008, Journal of dermatological science.

[82]  P. LuValle,et al.  Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression , 2008, Mechanisms of Development.

[83]  K. Urabe,et al.  Overexpression of phosphorylated‐ATF2 and STAT3 in cutaneous angiosarcoma and pyogenic granuloma , 2008, Journal of cutaneous pathology.

[84]  Zhen Yan,et al.  Functional interaction of regulatory factors with the Pgc-1alpha promoter in response to exercise by in vivo imaging. , 2008, American journal of physiology. Cell physiology.

[85]  M. Layne,et al.  Transforming Growth Factor β Up-regulates Cysteine-rich Protein 2 in Vascular Smooth Muscle Cells via Activating Transcription Factor 2* , 2008, Journal of Biological Chemistry.

[86]  W. Gao,et al.  The JNK/AP1/ATF2 pathway is involved in H2O2-induced acetylcholinesterase expression during apoptosis , 2008, Cellular and Molecular Life Sciences.

[87]  J. Licht,et al.  ATF-2 controls transcription of Maspin and GADD45α genes independently from p53 to suppress mammary tumors , 2008, Oncogene.

[88]  P. Meltzer,et al.  Suppressor role of activating transcription factor 2 (ATF2) in skin cancer , 2008, Proceedings of the National Academy of Sciences.

[89]  K. Urabe,et al.  Overexpression of phosphorylated ATF2 and STAT3 in eccrine porocarcinoma and eccrine poroma. , 2008, Journal of dermatological science.

[90]  E. Patterson,et al.  A neonatal encephalopathy with seizures in standard poodle dogs with a missense mutation in the canine ortholog of ATF2 , 2008, Neurogenetics.

[91]  M. Gorospe,et al.  Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells. , 2007, Molecular biology of the cell.

[92]  Zhongmin Yuan,et al.  dp5/HRK Is a c-Jun Target Gene and Required for Apoptosis Induced by Potassium Deprivation in Cerebellar Granule Neurons* , 2007, Journal of Biological Chemistry.

[93]  A. Flenniken,et al.  Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. , 2007, Genes & development.

[94]  P. Cole,et al.  Multiple roles for acetylation in the interaction of p300 HAT with ATF-2. , 2007, Biochemistry.

[95]  K. Docherty,et al.  ATF-2 stimulates the human insulin promoter through the conserved CRE2 sequence. , 2007, Biochimica et Biophysica Acta.

[96]  Koichi Nagasaki,et al.  Reduced Levels of ATF-2 Predispose Mice to Mammary Tumors , 2006, Molecular and Cellular Biology.

[97]  P. Lichter,et al.  JunB is required for endothelial cell morphogenesis by regulating core-binding factor β , 2006, The Journal of cell biology.

[98]  M. Dragunow,et al.  Activation of activating transcription factor 2 by p38 MAP kinase during apoptosis induced by human amylin in cultured pancreatic β‐cells , 2006, The FEBS journal.

[99]  H. van Dam,et al.  The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2. , 2006, Molecular endocrinology.

[100]  Shu-Yuan Cheng,et al.  Prolonged Activation of cAMP-response Element-binding Protein and ATF-2 Needed for Nicotine-triggered Elevation of Tyrosine Hydroxylase Gene Transcription in PC12 Cells* , 2006, Journal of Biological Chemistry.

[101]  Jian Jian Li,et al.  Mutual regulation of c‐Jun and ATF2 by transcriptional activation and subcellular localization , 2006, The EMBO journal.

[102]  H. Yoshioka,et al.  CREB-AP1 Protein Complexes Regulate Transcription of the Collagen XXIV Gene (Col24a1) in Osteoblasts* , 2006, Journal of Biological Chemistry.

[103]  M. Dragunow,et al.  Activating transcription factor 2 expression in the adult human brain: Association with both neurodegeneration and neurogenesis , 2005, Neuroscience.

[104]  H. van Dam,et al.  Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[105]  Ze'ev Ronai,et al.  ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. , 2005, Molecular cell.

[106]  J. Bailey,et al.  Identification of human myometrial target genes of the c-Jun NH2-terminal kinase (JNK) pathway: the role of activating transcription factor 2 (ATF2) and a novel spliced isoform ATF2-small. , 2005, Journal of molecular endocrinology.

[107]  Michael McClelland,et al.  Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. , 2004, Molecular cell.

[108]  Z. Ronai,et al.  Inhibition of Melanoma Growth and Metastasis by ATF2-Derived Peptides , 2004, Cancer Research.

[109]  Claudio R. Santos,et al.  Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK* , 2004, Journal of Biological Chemistry.

[110]  A. V. van Kessel,et al.  Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. , 2004, Nucleic acids research.

[111]  V. Carraro,et al.  Induction of CHOP Expression by Amino Acid Limitation Requires Both ATF4 Expression and ATF2 Phosphorylation* , 2004, Journal of Biological Chemistry.

[112]  Mohamed Hamdi,et al.  Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2 , 2003, Oncogene.

[113]  M. Hagiwara,et al.  Identification of ATF-2 as a Transcriptional Regulator for the Tyrosine Hydroxylase Gene* , 2002, The Journal of Biological Chemistry.

[114]  Z. Ronai,et al.  An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. , 2002, The Journal of clinical investigation.

[115]  T. Nishihara,et al.  p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. , 2002, Endocrinology.

[116]  K. Kooistra,et al.  Growth factors can activate ATF2 via a two‐step mechanism: phosphorylation of Thr71 through the Ras–MEK–ERK pathway and of Thr69 through RalGDS–Src–p38 , 2002, The EMBO journal.

[117]  M. Horikoshi,et al.  JDP2, a Repressor of AP-1, Recruits a Histone Deacetylase 3 Complex To Inhibit the Retinoic Acid-Induced Differentiation of F9 Cells , 2002, Molecular and Cellular Biology.

[118]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[119]  J. Bailey,et al.  Characterization and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labor: identification of a novel ATF2 species with potent transactivation properties. , 2002, The Journal of clinical endocrinology and metabolism.

[120]  C. Albanese,et al.  TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. , 2001, Molecular biology of the cell.

[121]  B. Kaina,et al.  Transcriptional activation of the small GTPase gene rhoB by genotoxic stress is regulated via a CCAAT element. , 2001, Nucleic acids research.

[122]  Z. Ronai,et al.  Stability of the ATF2 Transcription Factor Is Regulated by Phosphorylation and Dephosphorylation* , 2000, The Journal of Biological Chemistry.

[123]  P. Verde,et al.  Role of Distinct Mitogen-Activated Protein Kinase Pathways and Cooperation between Ets-2, ATF-2, and Jun Family Members in Human Urokinase-Type Plasminogen Activator Gene Induction by Interleukin-1 and Tetradecanoyl Phorbol Acetate , 1999, Molecular and Cellular Biology.

[124]  L. Glimcher,et al.  Mouse ATF-2 Null Mutants Display Features of a Severe Type of Meconium Aspiration Syndrome* , 1999, The Journal of Biological Chemistry.

[125]  Z. Ronai,et al.  Ubiquitination and Degradation of ATF2 Are Dimerization Dependent , 1999, Molecular and Cellular Biology.

[126]  N. Franchimont,et al.  Platelet-derived Growth Factor Induces Interleukin-6 Transcription in Osteoblasts through the Activator Protein-1 Complex and Activating Transcription Factor-2* , 1999, The Journal of Biological Chemistry.

[127]  R. Pestell,et al.  Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[128]  T. Nakamura,et al.  Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. , 1998, Experimental cell research.

[129]  N. Jones,et al.  p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. , 1998, Genes & development.

[130]  D. Hume,et al.  Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. , 1997, Gene.

[131]  T. Collins,et al.  Tumor Necrosis Factor α-Induced E-selectin Expression Is Activated by the Nuclear Factor-κB and c-JUN N-terminal Kinase/p38 Mitogen-activated Protein Kinase Pathways* , 1997, The Journal of Biological Chemistry.

[132]  W. M. Weaver,et al.  The Proximal Regulatory Element of the Interferon-γ Promoter Mediates Selective Expression in T Cells* , 1996, The Journal of Biological Chemistry.

[133]  X. Y. Li,et al.  Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. , 1996, Genes & development.

[134]  R. Sidman,et al.  Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice , 1996, Nature.

[135]  N. Jones,et al.  ATF‐2 contains a phosphorylation‐dependent transcriptional activation domain. , 1995, The EMBO journal.

[136]  Jiahuai Han,et al.  Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.

[137]  B. Dérijard,et al.  Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.

[138]  C. Y. Chen,et al.  Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation. , 1993, Oncogene.

[139]  J. Avruch,et al.  Activating transcription factor-2 DNA-binding activity is stimulated by phosphorylation catalyzed by p42 and p54 microtubule-associated protein kinases. , 1992, Molecular endocrinology.

[140]  Michael R. Green,et al.  Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2 , 1992, Nature.

[141]  C. Tanaka,et al.  Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. , 1991, Oncogene.

[142]  Tsonwin Hai,et al.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[143]  T. Nagase,et al.  Promoter region of the human CRE-BP1 gene encoding the transcriptional regulator binding to the cyclic AMP response element. , 1990, The Journal of biological chemistry.

[144]  M. Yoshida,et al.  Leucine zipper structure of the protein CRE‐BP1 binding to the cyclic AMP response element in brain. , 1989, The EMBO journal.